ARWRSTOCK_USDT
幣種名稱 ARWRSTOCK
流通率 0.00%
交易規則 (ARWRUSDT Perpetual)
槓桿倍數 1 ~ 20
最小下單數量 0.8721 USDT
市價單單筆最大下單數量 47,965.5 USDT
限價單單筆最大下單數量 47,965.5 USDT
最小變動價位 0.01
限價訂單價格上限/下限比例 20% / 20%
最大掛單數量 50
價差保護閾值 10%
合約面值 1 張 = 0.01 ARWR
強平手續費率 0.02%
查看所有合約交易規則基於各類指標等數據計算得到的分析，用於輔助判斷買入和賣出訊號。
數值指標
| 名稱 | 數值 | 操作 |
|---|
| KDJ (9,3,3)_K | | 中立 |
| KDJ (9,3,3)_D | | 中立 |
| KDJ (9,3,3)_J | | 中立 |
| RSI (14) | 0 | 買入 |
| StochRSI (%K) | 0 | 買入 |
| StochRSI (%D) | 0 | 買入 |
多維度指標
| 名稱 | 操作 |
|---|
| KDJ (9,3,3)_K&D | 中立 |
| KDJ (9,3,3) 金叉死叉 | 中立 |
| MACD (12,26,9) 金叉死叉 | 中立 |
| DEA 穿過零軸 | 中立 |
| BOLL (20,2) 超買超賣 | 中立 |
| BOLL (20,2) 中軌金叉死叉 | 中立 |
總結: 賣出 0 · 中立 9 · 買入 3 — 中立
簡介
Arrowhead Pharmaceuticals, Inc. has developed a drug that treats intractable diseases by inhibiting the genes that cause them, thus silencing the genes. Arrowhead therapy utilizes a wide range of RNA chemicals and efficient delivery methods to trigger RNA interference mechanisms, inducing rapid, deep, and durable knockout of target genes. RNA interference (RNAi) is a mechanism present in living cells that inhibits the expression of specific genes, thereby affecting the production of specific proteins. RNAi is considered one of the most important recent discoveries in life sciences, with the potential to revolutionize medicine. The discoverers of RNAi were awarded the Nobel Prize in 2006 for their work. Arrowhead Pharmaceuticals, Inc.'s RNAi-based therapy utilizes this natural pathway of gene silencing.
Disclaimer: Data is collected from third-party platforms, provided for reference only, and does not constitute any form of investment advice or guarantee.
